Section The Corynebacterineae suborder encompasses many infectious agents, including deadly human pathogens, such as Mycobacterium tuberculosis (M. tb). Many antibiotics used to treat M. tb block steps in cell envelope assembly, underscoring the key role of this protective barrier. The Corynebacterineae cell envelope is unique in that it is constructed from saccharide and lipid building blocks that differ dramatically even from those used by other bacteria. One of the central features of the Corynebacterineae cell envelope is the mycolyl arabinogalactan (mAG), which is a glycoconjugate assembled from galactofuranose (Galf), arabinofuranose (Araf), and mycolic acids. Most enzymes involved in mAG biosynthesis have been identified but when, where, and how they function in live cells to construct and remodel the cell envelope is not known. To elucidate these changes and their functional roles, the proposed aims focus on developing new tools to probe, perturb, and exploit changes in the Corynebacterineae cell envelope. The focus of Aim 1 is on generating a small molecule probe of the galactan?the only major cell wall constituent for which no effective probes exist. The target enzyme is UDP- galactopyranose mutase (UGM), which catalyzes the formation of the key building block required for biosynthesis of the essential galactan. The small molecule probe that results can be used to evaluate the consequences of blocking galactan assembly to understand the role of galactan in the stability and integrity of the cell envelope in Corynebacterineae and to probe the role of UGM in other organisms.
Aim 3 focuses on the mycolyltransferases, which construct the critical mycolic acid components of the cell envelope. The localization of these enzymes and the timing of their activity in cell division is not known. To visualize mycolyltransferase activity in live cells, we propose to devise fluorogenic probes that can pinpoint the sites of Ag85 activity and reveal the interplay between mycolyltransferase activity and cell envelope assembly. We anticipate that the probes described in Aim 3 can be used to develop assays for finding inhibitors of cell division and for monitoring and detecting mycobacteria in real time. We expect that our pursuit of the three aims shall uncover vulnerabilities in the defenses of mycobacteria and corynebacteria that will lead to new antibiotic strategies. Significance: The overall objective of this application is to develop new chemical probes to understand how the Corynebacterineae build and maintain their cell wall to survive. We anticipate that this knowledge will lead ultimately to the identification of new strategies to treat infectious disease.

Public Health Relevance

New strategies are needed to attack the growing prevalence of drug-resistant strains of bacteria, including Mycobacterium tuberculosis, the causative agent of tuberculosis. Because of their unique cell wall, mycobacteria can survive under conditions that would be deadly for most microbes; therefore, the focus of this project is on understanding how mycobacteria and related species build and remodel their cell wall. The identification of weak links in the cell wall can lead to antimycobacterial strategies that exploit these vulnerabilities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI126592-04
Application #
9625811
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Boyce, Jim P
Project Start
2017-02-01
Project End
2022-01-31
Budget Start
2019-02-01
Budget End
2020-01-31
Support Year
4
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Massachusetts Institute of Technology
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
001425594
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Hodges, Heather L; Brown, Robert A; Crooks, John A et al. (2018) Imaging mycobacterial growth and division with a fluorogenic probe. Proc Natl Acad Sci U S A 115:5271-5276
Wangkanont, Kittikhun; Winton, Valerie J; Forest, Katrina T et al. (2017) Conformational Control of UDP-Galactopyranose Mutase Inhibition. Biochemistry 56:3983-3992
Winton, Valerie J; Justen, Alexander M; Deng, Helen et al. (2017) Deleterious Consequences of UDP-Galactopyranose Mutase Inhibition for Nematodes. ACS Chem Biol 12:2354-2361
Wesener, Darryl A; Dugan, Amanda; Kiessling, Laura L (2017) Recognition of microbial glycans by soluble human lectins. Curr Opin Struct Biol 44:168-178
Wesener, Darryl A; Levengood, Matthew R; Kiessling, Laura L (2017) Comparing Galactan Biosynthesis in Mycobacterium tuberculosis and Corynebacterium diphtheriae. J Biol Chem 292:2944-2955
Winton, Valerie J; Aldrich, Claudia; Kiessling, Laura L (2016) Carboxylate Surrogates Enhance the Antimycobacterial Activity of UDP-Galactopyranose Mutase Probes. ACS Infect Dis 2:538-43